Pineal Gland Peptides Restore Melatonin Rhythm in Aging Monkeys and Humans
Background
Aging is associated with a decline in the pineal gland's function, leading to decreased melatonin production and a disrupted circadian rhythm. This disruption contributes to various age-related health issues, including sleep disturbances and immune dysfunction. This study specifically addresses how pineal gland peptide preparations might restore healthy melatonin secretion patterns in older individuals and animals.
Results
The study observed that both Epithalamin and Epitalon effectively modulated pineal gland function. In aging subjects, baseline melatonin levels were decreased at night and on average daily, with a reduced circadian rhythm amplitude. Post-treatment, the peptide preparations led to a recovery of endogenous night melatonin release. In elderly people, specifically those with functional insufficiency of the pineal gland, there was a significant increase in night melatonin levels. The preparations successfully normalized the hormone's circadian rhythm in the blood plasma. The most important finding was the complete normalization of the daily melatonin rhythm in both old monkeys and elderly people, reversing age-related declines.
Why It Matters
This research highlights the potential of pineal gland peptides to counteract age-related melatonin deficiency, a common issue contributing to sleep disorders and other health problems in the elderly. By restoring the natural circadian rhythm, these peptides could improve overall health and quality of life in aging populations. The finding that these preparations effectively increase melatonin concentration with no reported side effects is particularly promising. This suggests that Epithalamin and Epitalon could be safely integrated into clinical geriatric practice as a therapeutic intervention for age-related melatonin dysregulation, potentially paving the way for larger human trials.